505PApatinib plus docetaxel as second-line treatment in patients with advanced non-small cell lung cancer (NSCLC) (NCT02780778)
2018
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI